US Patent Issued to SCENT MEDICAL TECHNOLOGIES on May 27 for "Methods and system for associating between discharge of chemicals, and corresponding genetic, medical and/or pathological conditions" (Israeli, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,746, issued on May 27, was assigned to SCENT MEDICAL TECHNOLOGIES LTD (Tel Aviv, Israel).

"Methods and system for associating between discharge of chemicals, and corresponding genetic, medical and/or pathological conditions" was invented by Harel Hershtik (Rehovot, Israel), Drew Morris (North Potomac, Md.) and Ehud Cantor (Kfar Saba, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method is for determining the effect of a selected treatment administered to a patient. The method includes acquiring VOC-emission-data of pre-treatment-target-cells-cultures and producing a pre-treatment-target cells-VOC-profile from the VOC-emission of the pre-tr...